pharma ceo

Martin Shkreli, 32, is a former hedge fund manager and current CEO of Turing Pharmaceuticals. He recently raised the price of Daraprim, which is a medication used to treat HIV and cancer patients, from $13.50 to $750 per pill. Outside of his day job, Shkreli is also a major investor in Geoff Rickly's label, Collect Records. […]